OPKO Health (OPK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
02-28

For the quarter ended December 2024, OPKO Health (OPK) reported revenue of $183.6 million, up 0.9% over the same period last year. EPS came in at $0.01, compared to -$0.09 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $155.14 million, representing a surprise of +18.35%. The company delivered an EPS surprise of +109.09%, with the consensus EPS estimate being -$0.11.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how OPKO Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenues- Revenue from transfer of intellectual property and other: $43.10 million compared to the $14.89 million average estimate based on five analysts. The reported number represents a change of +193.2% year over year.
  • Revenues- Revenue from products: $37.40 million versus the five-analyst average estimate of $42.96 million. The reported number represents a year-over-year change of -13%.
  • Revenues- Revenue from services: $103.10 million versus $97.29 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -17% change.
View all Key Company Metrics for OPKO Health here>>>

Shares of OPKO Health have returned +10.7% over the past month versus the Zacks S&P 500 composite's -2.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

OPKO Health, Inc. (OPK) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10